FR2827302B1 - Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations - Google Patents
Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisationsInfo
- Publication number
- FR2827302B1 FR2827302B1 FR0109352A FR0109352A FR2827302B1 FR 2827302 B1 FR2827302 B1 FR 2827302B1 FR 0109352 A FR0109352 A FR 0109352A FR 0109352 A FR0109352 A FR 0109352A FR 2827302 B1 FR2827302 B1 FR 2827302B1
- Authority
- FR
- France
- Prior art keywords
- transgenic cell
- modeling human
- animal modeling
- antigenic presentation
- human antigenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70517—CD8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0381—Animal model for diseases of the hematopoietic system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/02—Cells from transgenic animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0109352A FR2827302B1 (fr) | 2001-07-13 | 2001-07-13 | Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations |
PCT/FR2002/002475 WO2003006639A1 (fr) | 2001-07-13 | 2002-07-12 | Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations |
EP02784869A EP1414949A1 (fr) | 2001-07-13 | 2002-07-12 | Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations |
CA002453928A CA2453928A1 (fr) | 2001-07-13 | 2002-07-12 | Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations |
US10/483,569 US20050066375A1 (en) | 2001-07-13 | 2002-07-12 | Cell and transgenic animal modelling human antigenic presentation and their uses |
US11/709,838 US20070209083A1 (en) | 2001-07-13 | 2007-02-23 | Cell and transgenic animal modelling human antigenic presentation and their uses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0109352A FR2827302B1 (fr) | 2001-07-13 | 2001-07-13 | Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2827302A1 FR2827302A1 (fr) | 2003-01-17 |
FR2827302B1 true FR2827302B1 (fr) | 2003-10-10 |
Family
ID=8865469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0109352A Expired - Fee Related FR2827302B1 (fr) | 2001-07-13 | 2001-07-13 | Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations |
Country Status (5)
Country | Link |
---|---|
US (2) | US20050066375A1 (fr) |
EP (1) | EP1414949A1 (fr) |
CA (1) | CA2453928A1 (fr) |
FR (1) | FR2827302B1 (fr) |
WO (1) | WO2003006639A1 (fr) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5478003B2 (ja) * | 2003-07-10 | 2014-04-23 | アンスティチュ パストゥール | ヒトの主要組織適合複合体(mhc)の表現型を有するトランスジェニックマウス、その実験のための使用および応用方法 |
US7663017B2 (en) | 2003-07-30 | 2010-02-16 | Institut Pasteur | Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications |
GB0425713D0 (en) * | 2004-11-23 | 2004-12-22 | Baker Matthew | Immunogencity testing and antibody selection methods |
FR2882628B1 (fr) * | 2005-03-04 | 2011-03-18 | Centre Nat Rech Scient | Souris transgeniques et leurs applications comme modele experimental |
EP1743904A3 (fr) * | 2005-07-13 | 2007-02-14 | F. Hoffmann-La Roche Ag | Chymase du cobaye |
US20090328240A1 (en) * | 2008-06-24 | 2009-12-31 | Sing George L | Genetically modified mice as predictors of immune response |
NZ592308A (en) * | 2008-09-30 | 2012-11-30 | Ablexis Llc | Non-human mammals for the production of chimeric antibodies |
EP2421980A2 (fr) * | 2009-04-23 | 2012-02-29 | Transposagen Biopharmaceuticals, Inc. | Rats génétiquement modifiés comme modèles de cancer |
WO2011002988A1 (fr) | 2009-07-01 | 2011-01-06 | Transposagen Biopharmaceuticals, Inc. | Modèles de rats génétiquement modifiés pour l'immunodéficience combinée sévère |
EP2564695B1 (fr) | 2009-07-08 | 2015-04-15 | Kymab Limited | Modèles animaux et molécules thérapeutiques |
US20120204278A1 (en) | 2009-07-08 | 2012-08-09 | Kymab Limited | Animal models and therapeutic molecules |
US9445581B2 (en) | 2012-03-28 | 2016-09-20 | Kymab Limited | Animal models and therapeutic molecules |
EP2456876A2 (fr) | 2009-07-24 | 2012-05-30 | Transposagen Biopharmaceuticals, Inc. | Modèles rats génétiquement modifiös pour les voies de signalisation cytokine-cytokine |
WO2011014721A2 (fr) | 2009-07-30 | 2011-02-03 | Transposagen Biopharmaceuticals, Inc. | Modèles de rat génétiquement modifiés pour pharmacocinétique |
US20110035816A1 (en) * | 2009-08-05 | 2011-02-10 | Ostertag Eric M | Genetically Modified Rat Models for Drug Metabolism |
EP2467013A2 (fr) | 2009-08-20 | 2012-06-27 | Transposagen Biopharmaceuticals, Inc. | Modèles de rat génétiquement modifié pour l'analyse de la douleur |
NZ601171A (en) | 2010-03-31 | 2014-11-28 | Ablexis Llc | Genetic engineering of non-human animals for the production of chimeric antibodies |
US20120020938A1 (en) * | 2010-07-26 | 2012-01-26 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | MHC- less cells |
US20120020885A1 (en) * | 2010-07-26 | 2012-01-26 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | MHC-Less cells |
NZ707327A (en) * | 2010-08-02 | 2017-01-27 | Regeneron Pharma | Mice that make binding proteins comprising vl domains |
US20130291134A1 (en) * | 2010-09-24 | 2013-10-31 | Sofia A. Casares | Humanized transgenic mouse model |
WO2012039779A1 (fr) * | 2010-09-24 | 2012-03-29 | The United States Of America As Represented By The Secretary Of The Navy | Modèle de souris transgénique humanisée |
CN105950654B (zh) * | 2010-11-27 | 2020-03-20 | 朱坚 | 一种人源化的转基因动物 |
WO2012129198A1 (fr) | 2011-03-23 | 2012-09-27 | Transposagen Biopharmaceuticals, Inc. | Modèles de rat génétiquement modifiés pour l'étude de l'obésité et du diabète |
WO2013017545A1 (fr) * | 2011-07-29 | 2013-02-07 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Souris transgéniques humanisées hla-a2 / hla-dp4 et leurs utilisations en tant que modèle expérimental pour la recherche biomédicale et le développement biomédical |
WO2013041844A2 (fr) | 2011-09-19 | 2013-03-28 | Kymab Limited | Anticorps, domaines variables & chaînes adaptées pour une utilisation humaine |
WO2013045916A1 (fr) | 2011-09-26 | 2013-04-04 | Kymab Limited | Chaînes légères substituts (cls) chimères comprenant vpreb humain |
GB201116721D0 (en) | 2011-09-28 | 2011-11-09 | Glaxo Group Ltd | Novel device |
US9043996B2 (en) | 2011-10-28 | 2015-06-02 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex animals |
LT3590332T (lt) | 2011-10-28 | 2022-08-10 | Regeneron Pharmaceuticals, Inc. | Genetiškai modifikuotos pelės, ekspresuojančios chimerines pagrindinio audinių dermės komplekso (mhc) ii molekules |
RU2653433C2 (ru) * | 2011-10-28 | 2018-05-08 | Регенерон Фармасьютикалс, Инк. | Генетически модифицированные в отношении главного комплекса гистосовместимости мыши |
US9591835B2 (en) | 2011-10-28 | 2017-03-14 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex animals |
SI2771357T1 (sl) * | 2011-10-28 | 2018-11-30 | Regeneron Pharmaceuticals, Inc. | Genetsko T-celično receptorsko modificirane miši |
CN107254480B (zh) * | 2011-10-28 | 2021-08-10 | 瑞泽恩制药公司 | 制备主要组织相容性复合物基因修饰小鼠的方法 |
US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
US10251377B2 (en) | 2012-03-28 | 2019-04-09 | Kymab Limited | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies |
GB2502127A (en) | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
SI2958938T1 (sl) | 2013-02-20 | 2019-08-30 | Regeneron Pharmaceuticals, Inc. | Miši, ki izražajo humanizirane koreceptorje za celice T |
US20150342163A1 (en) | 2013-02-22 | 2015-12-03 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex mice |
CN105164154B (zh) * | 2013-02-22 | 2019-06-07 | 瑞泽恩制药公司 | 表达人源化主要组织相容性复合物的小鼠 |
CN105208855B (zh) * | 2013-03-11 | 2018-04-27 | 瑞泽恩制药公司 | 表达嵌合的主要组织相容性复合物(mhc)ii类分子的转基因小鼠 |
WO2014164640A1 (fr) * | 2013-03-11 | 2014-10-09 | Regeneron Pharmaceuticals, Inc. | Souris transgéniques exprimant des molécules chimériques du complexe majeur d'histocompatibilité (cmh) de classe i |
US9788534B2 (en) | 2013-03-18 | 2017-10-17 | Kymab Limited | Animal models and therapeutic molecules |
US9783618B2 (en) | 2013-05-01 | 2017-10-10 | Kymab Limited | Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
US11707056B2 (en) | 2013-05-02 | 2023-07-25 | Kymab Limited | Animals, repertoires and methods |
US9783593B2 (en) | 2013-05-02 | 2017-10-10 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
DE112014004537T5 (de) | 2013-10-01 | 2016-07-21 | Kymab Limited | Tiermodelle und therapeutische Moleküle |
WO2015056774A1 (fr) * | 2013-10-18 | 2015-04-23 | 大鵬薬品工業株式会社 | Animal non humain exprimant une molécule hla classe i |
SG11201607015VA (en) | 2014-03-21 | 2016-09-29 | Regeneron Pharma | V<sb>L</sb> ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS |
SG11201607203XA (en) | 2014-03-21 | 2016-09-29 | Regeneron Pharma | Non-human animals that make single domain binding proteins |
AU2015353705C9 (en) * | 2014-11-24 | 2022-09-01 | Regeneron Pharmaceuticals, Inc. | Non-human animals expressing humanized CD3 complex |
AU2016220324B2 (en) | 2015-02-16 | 2020-07-02 | The Trustees Of The University Of Pennsylvania | A fully-human T cell receptor specific for the 369-377 epitope derived from the HER2/Neu (ERBB2) receptor protein |
CA2979702A1 (fr) | 2015-03-19 | 2016-09-22 | Regeneron Pharmaceuticals, Inc. | Animaux non humains qui selectionnent des regions variables de chaines legeres qui se lient a l'antigene |
BR112017021250A2 (pt) | 2015-04-06 | 2018-06-26 | Regeneron Pharma | respostas imunes mediadas por células t humanizadas em animais não humanos |
US11612149B2 (en) | 2015-07-10 | 2023-03-28 | Chugai Seiyaku Kabushiki Kaisha | Non-human animal having human CD3 gene substituted for endogenous CD3 gene |
WO2017150763A1 (fr) * | 2016-02-29 | 2017-09-08 | (주)메디톡스 | Modèle animal exprimant cd3 humain et son utilisation |
JP7125347B2 (ja) | 2016-08-22 | 2022-08-24 | 中外製薬株式会社 | ヒトgpc3ポリペプチドを発現する遺伝子改変非ヒト動物 |
EP4144213A1 (fr) | 2017-05-12 | 2023-03-08 | The Jackson Laboratory | Souris nsg dépourvues de mhc de classe i et de classe ii |
CN109136261B (zh) | 2017-06-19 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化cd28基因改造动物模型的制备方法及应用 |
US11712026B2 (en) * | 2017-10-18 | 2023-08-01 | The Jackson Laboratory | Murine-MHC-deficient HLA-transgenic nod-mouse models for T1D therapy development |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5489742A (en) * | 1990-10-23 | 1996-02-06 | Board Of Regents, The University Of Texas System | Transgenic rats and animal models of inflammatory disease |
WO1993005817A1 (fr) * | 1991-09-19 | 1993-04-01 | President And Fellows Of Harvard College | Mammiferes transgeniques depourvus des antigenes des classes mhc i et ii |
WO1995014377A2 (fr) * | 1993-11-29 | 1995-06-01 | Amgen Canada Inc. | Modele pour maladies infectieuses |
US5965787A (en) * | 1995-08-31 | 1999-10-12 | Mayo Foundation For Medical Education And Research | HLA-DRBI peptides with specific binding affinity for HLA-DQ molecules: prevention and treatment of rheumatoid arthritis |
WO1997032978A1 (fr) * | 1996-03-06 | 1997-09-12 | The Uab Research Foundation | Production d'hemoglobine humaine dans des animaux transgeniques |
WO1998008943A1 (fr) * | 1996-08-30 | 1998-03-05 | Mayo Foundation For Medical Education And Research | Peptides de hla-drb1 ayant une affinite de liaison specifique pour les molecules de hla-dq et utiles dans la prevention et le traitement de la polyarthrite rhumatoide |
US6255555B1 (en) * | 1997-04-17 | 2001-07-03 | Japan Science And Technology Corporation | Transgenic mouse expressing human fusin and human CD4 |
US6833268B1 (en) * | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
-
2001
- 2001-07-13 FR FR0109352A patent/FR2827302B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-12 US US10/483,569 patent/US20050066375A1/en not_active Abandoned
- 2002-07-12 EP EP02784869A patent/EP1414949A1/fr not_active Withdrawn
- 2002-07-12 WO PCT/FR2002/002475 patent/WO2003006639A1/fr not_active Application Discontinuation
- 2002-07-12 CA CA002453928A patent/CA2453928A1/fr not_active Abandoned
-
2007
- 2007-02-23 US US11/709,838 patent/US20070209083A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20070209083A1 (en) | 2007-09-06 |
CA2453928A1 (fr) | 2003-01-23 |
US20050066375A1 (en) | 2005-03-24 |
WO2003006639A1 (fr) | 2003-01-23 |
FR2827302A1 (fr) | 2003-01-17 |
EP1414949A1 (fr) | 2004-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2827302B1 (fr) | Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations | |
FR16C1012I2 (fr) | Utilisation therapeutique d'anticorps anti-cs1 | |
MA30684B1 (fr) | Anticorps anti-mn et leurs procedes d'utilisation. | |
DE60324099D1 (de) | Arzneistoffhaltiger tampon | |
FR2888850B1 (fr) | Nouveaux anticorps anti-igf-ir et leurs applications | |
CY2011003I2 (el) | Φαρμακευτικα προϊοντα σε διαλυμα που περιεχουν αντισωμα | |
FR09C0062I2 (fr) | Anticorps de la il-1 beta humaine | |
DE60324178D1 (de) | THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN | |
DE60221143D1 (de) | Brusteinlage enthaltend hautpflegemittel | |
DK1713544T3 (da) | Sammensætninger og fremgangsmåder til oral og personlig pleje | |
NO20004907L (no) | Vandig emulsjon og fremstilling derav | |
DE60139763D1 (de) | Lanzen und -tieren | |
DE50213460D1 (de) | Spirocyclische 3-phenyl-3-substituierte-4-ketolaktame und -laktone | |
DK1589938T3 (da) | Mundplejesammensætninger og fremgangsmåder hertil | |
FR2834991B1 (fr) | Nouveaux anticorps anti-igf-ir et leurs applications | |
FR2848826B1 (fr) | Compositions cosmetiques et cartes de contraste permettant de les caracteriser | |
FR2834900B1 (fr) | Nouvelles compositions a activite anti-igf-ir et anti-egfr et leurs applications | |
FR2822161B1 (fr) | Cellule et animal transgenique modelisant les reponses humaines allergiques mediees par les ige, et leurs utilisations | |
DE60217668D1 (de) | Pflanzenfettemulsion enthaltend haferprotein | |
FR2864535B1 (fr) | Derives acides de quinoline et leurs applications en therapeutique | |
FR2850969B1 (fr) | Aminopropanediols acyles et analogues et leurs utilisations therapeutiques | |
IT1316921B1 (it) | Organo bioartificiale per ospitare cellule animali e/o umane. | |
FR2862995B1 (fr) | Poutre souple autocontrainte et portiques souples parasismiques | |
NO20042416L (no) | Farmasoytisk sammensetning for induksjon av en immunrespons i et menneske eller dyr | |
FR2846967B1 (fr) | Nouveaux composes lipophiles et leurs utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20150331 |